You are here

  • Home
  • Archive
  • Volume 7, Issue 2
  • Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis

Citation Tools

Article menu
XML
Meta-analysis
Original research
Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ssentongo AE, Ssentongo P, Heilbrunn ES, et al
Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis
Open Heart 2020;7:e001353. doi: 10.1136/openhrt-2020-001353